|
|
ORIGINAL ARTICLE |
|
Year : 2015 | Volume
: 14
| Issue : 3 | Page : 174-179 |
|
Hepatoprotective and in-vitro anti-HIV-1 effect of Alectryon tomentosus F. Muell leaf extract and its phytochemical profile
Elsayed Ali Aboutabl1, Salma A El-Sawi2, Amany A Sleem3, Khaled N Rashed2, Nermin A Ragab2, Yong-TangZheng4
1 Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, Egypt 2 Department of Pharmacognosy, National Research Centre, Giza, Egypt 3 Department of Pharmacology, National Research Centre, Giza, Egypt 4 Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China
Date of Submission | 14-Jun-2015 |
Date of Acceptance | 15-Jul-2015 |
Date of Web Publication | 30-Dec-2015 |
Correspondence Address: Salma A El-Sawi Prof, Department of Pharmacognosy, National Research Centre, 33 El Bohouth Street, Dokki, Giza 12622 Egypt
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1687-4315.172863
Objectives This work was designed to evaluate the therapeutic efficacy of Alectryon tomentosus F. Muell leaf extract against CCl 4 -induced hepatic injury in albino rats and anti-HIV effect in vitro. Proximate analysis, phytochemical screening and assay of total flavonoid (TFC) and phenolic contents (TPC), were carried out according to standard methods. Materials and methods The TPC and TFC were estimated spectrophotometrically. The median lethal dose (LD 50 ) of the total ethanol extract of A. tomentosus F. Muell leaves was evaluated. The effect on acute HIV-1 infectivity was measured with the syncytium formation assay using AZT (3΄-azido-3΄-deoxythymidine) as a positive control. Moreover, carbon tetrachloride-induced acute hepatic damage was used to evaluate the hepatoprotective effect of the leaves. Results and conclusion Proximate analysis of air-dried leaves of A. tomentosus F. Muell revealed 8.3% moisture content, 9.2% total ash, 0.48% water-soluble ash and 2.56% acid-insoluble ash. Preliminary phytochemical screening revealed that the dried powdered leaves of A. tomentosus F. Muell are rich in carbohydrates and/or glycosides, volatile constituents, sterols and/or triterpenes and tannins; however, flavonoids (free and combined) and coumarins are present in a lesser concentration. Alkaloids, saponins, cardiac glycosides and anthraquinones are absent. The evaluated TPC was 71.59 mg gallic acid equivalent/g dry weight, whereas TFC was 63.64 mg quercetin equivalent/g plant dry weight. The median lethal dose (LD 50 ) of the total ethanol extract was found to be 9.2 g/kg body weight, indicating the safety of the leaves of the plant. In carbon tetrachloride-induced acute hepatic damage model, the methylene chloride extract showed the highest protection percentage as shown by reduction in the level of aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase levels, followed by aqueous extract. These may be attributed to their phenolic and flavonoidal content. The anti-HIV-1 activity was assessed by evaluating syncytium formation. The results showed that the extract was minimally toxic and showed a weak anti-HIV-1 activity in comparison with AZT. Keywords: Alectryon tomentosus F. Muell, anti-HIV-1, flavonoids, hepatoprotective, phytochemical profile
How to cite this article: Aboutabl EA, El-Sawi SA, Sleem AA, Rashed KN, Ragab NA, YT. Hepatoprotective and in-vitro anti-HIV-1 effect of Alectryon tomentosus F. Muell leaf extract and its phytochemical profile. Egypt Pharmaceut J 2015;14:174-9 |
How to cite this URL: Aboutabl EA, El-Sawi SA, Sleem AA, Rashed KN, Ragab NA, YT. Hepatoprotective and in-vitro anti-HIV-1 effect of Alectryon tomentosus F. Muell leaf extract and its phytochemical profile. Egypt Pharmaceut J [serial online] 2015 [cited 2022 Aug 10];14:174-9. Available from: http://www.epj.eg.net/text.asp?2015/14/3/174/172863 |
Introduction | |  |
Phenolic compounds are plant substances that possess in common an aromatic ring bearing one or more hydroxyl groups. There are about 8000 naturally occurring plant phenolic compounds and about half of which are flavonoids [1]. Previous studies support the use of phenolic compounds in the treatment of hepatitis and other medical benefits, attributed to their anti-inflammatory effect [2],[3],[4]. Some phenolic compounds showed a potential anti-HIV-1 activity [5]. Furthermore, phenolic compounds possess a wide spectrum of biochemical activities such as antioxidant, antimutagenic, anticarcinogenic, as well as the ability to modify the gene expression [6]. Alectryon is a genus of trees in the family Sapindaceae and is found in the rainforests of Australia, Hawaii, Indonesia, Malaysia, New Zealand, Papua, New Guinea, Philippines and Samoa [7]. There are no previous phytochemical or biological studies reported on Alectryon tomentosus F. Muell leaves. Thus, the objective of this study was to determine the phytochemical constituents in general, and the total flavonoid (TFC) and the total phenolic content (TPC) in particular.
Materials and methods | |  |
Plant material
Fresh leaves of A. tomentosus F. Muell were obtained from Orman garden, Giza, Egypt, in April 2012. The plant was identified by Mrs Therese Labib, a plant taxonomist at Orman Garden, Giza, Egypt, and confirmed by the taxonomist, Dr M. El-Gebaly, NRC. A voucher specimen was kept in the Pharmacognosy Department, NRC. The leaves of the plant were air-dried, powdered and kept in tightly closed containers.
Preparation of the aqueous methanolic extract
The air-dried powdered leaves of the plant (200 g) were extracted by maceration with 70% aqueous methanol until exhaustion. The solvent was evaporated to dryness under reduced pressure to yield the crude extract of the plant leaves.
Preparation of the ethanolic extract
Extraction was carried out with 95% ethanol in a continuous extraction apparatus (Soxhlet) and evaporation of the solvent under reduced pressure.
Preparation of successive extracts
The air-dried powdered leaves of the plant (100 g) were successively extracted with petroleum ether, methylene chloride, ethyl acetate, butanol and water. Each extract was evaporated to dryness under reduced pressure. The solvent-free residue in each case was weighed.
Proximate analysis
The percentages of moisture content, total ash, water-soluble ash and acid-insoluble ash values were determined according to the Egyptian Pharmacopeia [8].
Preliminary phytochemical screening
All extracts were qualitatively screened for the presence of various groups of phytoconstituents using different chemical tests [9],[10].
Total phenolic assay
The TPC was determined applying the Folin-Ciocalteu colourimetric method using gallic acid as a standard and was expressed as milligrams of gallic acid equivalents/g of the dry plant material [11].
Total flavonoid assay
The TFC was measured using aluminium chloride colourimetric assay. Calibration curve was established using quercetin as a standard. TFC was expressed as mg quercetin equivalent/g of the dry plant material [12].
Bioactivity studies
Experimental animals
Adult albino rats of Sprague-Dawley strain weighing 130-150 g and albino mice weighing 25-30 g were obtained from the animal house colony of the National Research Centre, Dokki, Egypt. They were kept under the same hygienic conditions and well-balanced diet and water. Medical research ethical committee (MREC) in NRC has approved the work.
Normal diet
It consisted of vitamin mixture (1%), mineral mixture (4%), corn oil (10%), sucrose (20%), cellulose (0.2%), 95% pure casein (10.5%) and starch (54.3%).
Drug dosage
Doses of the standard drugs were calculated [13] and administered orally by means of a gastric tube.
Standard drugs, chemicals and biochemical kits
Carbon tetrachloride (Analar, Sigma, St. Louis, USA) was used as a hepatotoxic agent. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), blood urea nitrogen and blood glutathione kits were used (QCA, Tarragona, Spain). AZT (3΄-azido-3΄-deoxythymidine), used as a standard anti-HIV drug, was purchased from Sigma. AZT was dissolved in RPMI-1640 and stored at −20°C.
HEPES [N-2 (2-hydroxyethyl) piperazine-N'-(2-ethanesulfonic acid)], MTT [3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide], DMF (N, N'-dimethyl formamide), penicillin, streptomycin sulphate and glutamine were purchased from Sigma (Sigma, St. Louis, USA). 2-ME (2-mercaptoethanol) was purchased from Bio-Rad (Bio-Rad., California, USA). RPMI-1640 and fetal bovine serum were purchased from Gibco (for anti-HIV test).
Cell lines
HIV cell line: C8166 cells (a fusion of primary umbilical cord blood cells with an HTLV-1-producing line from an adult T-cell leukaemia lymphoma patient containing a defective HTLV-1 genome) and HIV-1IIIB were kindly donated by Medical Research Council, AIDS Regent Project. The cells were maintained at 37°C in 5% CO 2 in RPMI-1640 medium supplemented with 10% heat-inactivating fetal bovine serum (Gibco). The HIV-1IIIB was prepared from the supernatants of H9/HIV-1IIIB cells. The 50% HIV-1 tissue culture infectious dose (TCID50) in C8166 cells was determined and calculated [14]. Virus stocks were stored in small aliquots at -70°C.
Determination of median lethal dose (LD 50 )
The median lethal dose (LD 50 ) of total ethanol extract of A. tomentosus F. Muell was determined [15]. Male albino rats were divided into groups, each of six animals. Preliminary experiments were undertaken to determine the minimal dose that kills all animals (LD 100 ) and the maximal dose that fails to kill any animal. Several doses at equal logarithmic intervals were chosen between these two doses, and each dose was injected into a group of six animals subcutaneously. The mice were observed for 24 h; symptoms of toxicity and mortality rates in each group were recorded and LD 50 was calculated.
Evaluation of anti-HIV activity
Cytotoxicity assay
All experimental procedures were performed at the BSL-3 laboratory according to the safety guidelines of Kunming Institute of Zoology, Chinese Academy of Sciences. The cellular toxicity of the extracts on C8166 cells was assessed with the MTT colourimetric assay. A measure of 100 μl of 4 × 10 5 cells was plated into 96-well plates. This was followed by the addition of100 μl of various concentrations of compounds and incubation at 37°C in a humidified atmosphere of 5% CO 2 for 72 h; 100 μl of supernatant was discarded. MTT reagent was added and incubated for 4 h; and 100 μl 50% DMF-20% SDS was added. The formazan formed was dissolved completely; the plates were read by means of a Bio-Tek EL ΄800 ELISA reader at 570 nm/630 nm. The concentration that produces 50% cytotoxicity (CC 50 ) was calculated [16].
Inhibition of syncytium formation
Syncytium is a viral protein fusion at the host cell membrane during viral replication or induction of virus by host-cell-cell fusion resulting in a multinucleated giant cell. The effect of extract on acute HIV-1 infectivity was measured using the syncytium formation assay [17]. In the presence or absence of various concentrations of samples, 4 × 10 4 C8166 cells were infected with HIV-1 at a multiplicity of infection of 0.015 and cultured in 96-well plates at 37°C in 5% CO 2 for 3 days. The AZT was used as a positive control. At 3 days after infection, the cytopathic effect was measured by counting the number of syncytia in each well of 96-well plates under an inverted microscope (×100). The inhibitory percentage of syncytium formation was calculated by the percentage of syncytium number in a sample-treated culture compared with that in infected control culture. The 50% effective concentration (EC 50 ) was calculated according to the method described by Reed and Muench [14]. Fifty percent cytotoxic concentration (CC 50 ) and 50% effective concentration (EC 50 ) were determined from dose-response curve. The therapeutic index of anti-HIV activity is CC 50 /EC 50 .


where OD is optical density.
Evaluation of hepatoprotective activity
Induction of liver damage
Liver damage in rats was induced by means of intraperitoneal injection of 5 ml/kg of 25% carbon tetrachloride in liquid paraffin [18].
Experimental design
Forty-two male albino rats were randomly divided into seven groups of six rats each:
The first group, the control group, received a daily oral dose of 1 ml saline for 1 week before and after liver damage (negative control).
The second, third, fourth, fifth and sixth groups included liver-damaged rats pretreated with a daily oral dose of 100 mg/kg body weight of petroleum ether, methylene chloride, ethyl acetate and butanol extracts, respectively, for a week.
The seventh group included liver-damaged rats pretreated with a daily oral dose of 25 mg/kg body weight silymarin as a standard. Administration of the extracts and drug was continued after liver-damage for a week.
After an overnight fast, whole blood sample was withdrawn from the retro-orbital venous plexus through the eye canthus of anaesthetized rats. Blood samples were collected at zero time point, 1 week after extract adminstration, 72 h and 1 week after CCl 4 injection. Serum was isolated by centrifugation. Serum AST, ALT [19] and ALP [20] were measured.
Results and discussion | |  |
Proximate analysis
The estimated moisture content, total ash, water-soluble ash and acid-insoluble ash of the leaves were 8.31, 9.29, 0.48 and 2.56, respectively. These constants could be used as criteria for the identity and purity of A. tomentosus F. Muell leaves.
Phytochemical screening
Preliminary phytochemical screening revealed that the dried powdered leaves of A. tomentosus F. Muell are rich in carbohydrates and/or glycosides, volatile constituents, sterols and/or triterpenes and tannins, whereas flavonoids (free and combined) and coumarins are present in a lesser concentration. Alkaloids, saponins, cardenolides and anthraquinones are absent. Successive extracts were shown [Table 1] as percentage of yield, physical characters and phytoconstituents. The extracts prepared with polar solvents were rich in carbohydrates, flavonoidal contents and tannins. Sterols and/or triterpenes were present in the extracts prepared with nonpolar solvents. | Table 1: Percentages and physical and chemical characters of the successive extracts of Alectryon tomentosus F. Muell leaves
Click here to view |
Total phenolic and flavonoid contents
The TPC in A. tomentosus F. Muell leaves was found to be 71.59 mg gallic acid equivalent/g plant dry weight, whereas TFC in A. tomentosus F. Muell leaves was found to be 63.64 mg quercetin equivalent/g plant dry weight.
Median lethal dose (LD 50 )
LD 50 of the total ethanol extract was found to be 9.2 g/kg body weight, indicating the safety of the plant.
Hepatoprotective activity
[Table 2],[Table 3] and [Table 4] revealed that pretreatment of rats with the successive extracts of the leaves for a week before liver damage did not result in a significant change in AST, ALT and ALP as compared with silymarin, which is considered to be safe on the liver. After a week, liver damage was induced by means of intraperitoneal injection of CCl 4 . The methylene chloride leaf extract showed the least damage effect as shown by AST levels after 72 h of liver damage induction and thus has the highest level of protection followed by aqueous leaf extract. The methylene chloride extract showed the best treatment results as well, followed by ethyl acetate, after 7 days of treatment. | Table 2: Effect of successive extracts of Alectryon tomentosus F. Muell leaves and silymarin drug on serum aspartate aminotransferase (m/l) enzyme level on liver-damaged rats
Click here to view |
 | Table 3: Effect of successive extracts of Alectryon tomentosus F. Muell leaves and silymarin drug on serum alanine aminotransferase (m/l) enzymes level on liver-damaged rat
Click here to view |
 | Table 4: Effect of successive extracts of Alectryon tomentosus F. Muell leaves and silymarin drug on serum alkaline phosphatase enzymes level on liver-damaged rats
Click here to view |
The methylene chloride extract showed the least damage percentage as shown by ALT percentage, followed by aqueous extract, after 72 h. The methylene chloride extract showed the best treatment results as well, followed by ethyl acetate, after 7 days. The methylene chloride extract showed the least liver damage as shown by ALP percentage, followed by aqueous extract, after 72 h and 7 days.
These may be attributed to their terpenoidal, flavonoidal and phenolic content.
In-vitro evaluation of anti-HIV-1 activity of the total methanol extract of Alectryon tomentosus F. Muell leaves
The effect of extracts on acute HIV-1 infectivity was measured with the syncytia formation assay. AZT was used as a positive control. The cytopathic effect was measured by counting the number of syncytia (multinucleated giant cells) in each well of 96-well plates under microscope. The results [Table 5] and [Table 6] showed that the extract was minimally toxic and showed a weak anti-HIV-1 activity in comparison with AZT.
Conclusion | |  |
Phytochemical study of the leaves of A. tomentosus F. Muell revealed the presence of a variety of constituents in the plant, which contribute to the demonstrated bioactivities of the extracts prepared. Meanwhile, the plant has high LD 50 , indicating its low toxicity. This study deduced the potential hepatoprotective effect of A. tomentosus F. Muell leaves.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | |  |
1. | Harborne JB, Herbert H. Phytochemical dictionary: a handbook of bioactive compounds from plants. London: Taylor and Francis; 1993. |
2. | El sawi SA, Hemaia MM, El-Shabrawy O, Abdel-Rahman O. El-Shabrawy, Sleem MA, Sleem AA, et al. Ethenopharmacological in vivo studies on Juniperus pheoenica: evaluation of hepatoprotective role and anti-inflammatory action. J Basic Appl Res 2015; 5:157-165. |
3. | El sawi SA, Sleem AA. Flavonoids and hepatoprotective activity of leaves of Senna surattensis (Burm. f.) in CCl4 induced hepatotoxicity in rats. Aust J Basic Appl Sci 2010; 4:1326-1334. |
4. | El Alfy TS, El sawi SA, Sleem AA, Moawad DM. Investigation of flavonoidal content and biological activities of Chorisia Insiginis Hbk. leaves. Aust J Basic Appl Sci 2010; 4:1334-1348. |
5. | Wang WX, Qian JY, Wang XJ, Jiang AP, Jia AQ. Anti-HIV-1 activities of extracts and phenolics from Smilax china L. Pak J Pharm Sci 2014; 27:147-151. |
6. | Marinova D, Ribarova F, Atanassova M. Total phenolics and total flavonoids in Bulgarian fruits and vegetables. J Univ Chem Tech Metall 2005; 40:255-260. |
7. | Xia N, Gadek PA. Sapindaceae. In Zhengyi W, Raven PH, Deyuan H (eds.). In the Flora of China Science Press; St. louis, Missouri Botanical Gardens press 1848. |
8. | Egyptian pharmacopoeia. General organization for government printing affairs. Cairo: Central Administration and Pharmaceutical Affairs, Ministry of Health and Population; 2005. |
9. | Trease GE, Evans WC. Textbook of pharmacognosy. 12th ed. London: Balliere Tindall; 1989. |
10. | Harborne JB. Phytochemical methods - a guide to modern techniques of plant analysis. London: Chapman and Hall; 1998. |
11. | Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic phosphotungstic acid reagents. Am J Enol Vitic 1965; 16:144-158. |
12. | Zhishen J, Mengcheng T, Jianming, W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chemistry 1999; 64:555−559. |
13. | Paget G, Berne′s E. Toxicity tests in evaluation of drug activities ′cited in the laboratory rat′. editor Laurence DR. The laboratory rat. London: Bacharach AL Academic Press; 1964. 135-160. |
14. | Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493-497. |
15. | Karber G. Determination of LD 50 . Arch Exper Pathol Pharmacol 1931 ; 162:480. |
16. | Huang N, Yang LM, Li XL, Zheng CB, Wang RR, Yang YP, Zheng YT. Anti-HIV activities of extracts from Pu-erh tea. Chin J Nat Med 2012; 10:347-352. |
17. | Wang RR, Gu Q, Wang YH, Zhang XM, Yang LM, Zhou J, et al. Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis. J Ethnopharmacol 2008; 117:249-256. |
18. | Klassen CD, Plaa GL. Comparison of the biochemical alteration elicited in liver of rats treated with CCl4 and CHCl3. Toxicology App Pharm 1969; 18:2019-2022. |
19. | Thewfweld W. Enzymatic method for determination of serum AST and ALT. Dtsch Med Wochenschr 1974; 99:343-347. |
20. | Kind PR, King EG. Colorimetric method for the determination of serum ALP. J Clin Pathol 1954; 7:322-324. |
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]
|